- Home
- FUSB vs IMMX Comparison
FUSB vs IMMX Comparison
Compare FUSB & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- IMMX
- Stock Information
- Founded
- FUSB 1952
- IMMX 2014
- Country
- FUSB United States
- IMMX United States
- Employees
- FUSB N/A
- IMMX N/A
- Industry
- FUSB Major Banks
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- FUSB Finance
- IMMX Health Care
- Exchange
- FUSB Nasdaq
- IMMX Nasdaq
- Market Cap
- FUSB 72.6M
- IMMX 61.1M
- IPO Year
- FUSB N/A
- IMMX 2021
- Fundamental
- Price
- FUSB $13.00
- IMMX $2.65
- Analyst Decision
- FUSB
- IMMX Strong Buy
- Analyst Count
- FUSB 0
- IMMX 1
- Target Price
- FUSB N/A
- IMMX $7.00
- AVG Volume (30 Days)
- FUSB 2.2K
- IMMX 137.1K
- Earning Date
- FUSB 07-23-2025
- IMMX 08-11-2025
- Dividend Yield
- FUSB 2.15%
- IMMX N/A
- EPS Growth
- FUSB N/A
- IMMX N/A
- EPS
- FUSB 1.28
- IMMX N/A
- Revenue
- FUSB $38,449,000.00
- IMMX N/A
- Revenue This Year
- FUSB N/A
- IMMX N/A
- Revenue Next Year
- FUSB N/A
- IMMX N/A
- P/E Ratio
- FUSB $10.16
- IMMX N/A
- Revenue Growth
- FUSB N/A
- IMMX N/A
- 52 Week Low
- FUSB $9.17
- IMMX $1.26
- 52 Week High
- FUSB $14.30
- IMMX $3.00
- Technical
- Relative Strength Index (RSI)
- FUSB 53.63
- IMMX 61.44
- Support Level
- FUSB $12.53
- IMMX $2.16
- Resistance Level
- FUSB $13.23
- IMMX $2.80
- Average True Range (ATR)
- FUSB 0.26
- IMMX 0.17
- MACD
- FUSB 0.01
- IMMX 0.04
- Stochastic Oscillator
- FUSB 65.14
- IMMX 80.00
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.